Concepts (91)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Puberty, Delayed | 6 | 2022 | 115 | 3.610 |
Why?
|
| Puberty | 4 | 2019 | 490 | 1.720 |
Why?
|
| Puberty, Precocious | 3 | 2020 | 156 | 1.410 |
Why?
|
| Sexual Maturation | 3 | 2019 | 265 | 0.820 |
Why?
|
| Thyroiditis, Autoimmune | 1 | 2020 | 101 | 0.740 |
Why?
|
| Neonatal Screening | 2 | 2020 | 591 | 0.680 |
Why?
|
| Hypogonadism | 2 | 2015 | 799 | 0.660 |
Why?
|
| Adrenoleukodystrophy | 1 | 2020 | 123 | 0.660 |
Why?
|
| Growth Charts | 1 | 2019 | 61 | 0.640 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2022 | 370 | 0.620 |
Why?
|
| Cranial Irradiation | 1 | 2020 | 401 | 0.610 |
Why?
|
| Growth | 1 | 2019 | 376 | 0.570 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2020 | 703 | 0.560 |
Why?
|
| Body Height | 2 | 2020 | 1577 | 0.540 |
Why?
|
| Medulloblastoma | 1 | 2020 | 683 | 0.510 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2019 | 3336 | 0.490 |
Why?
|
| Malnutrition | 1 | 2020 | 625 | 0.470 |
Why?
|
| Fatty Acids | 1 | 2020 | 1809 | 0.430 |
Why?
|
| Models, Economic | 1 | 2016 | 713 | 0.420 |
Why?
|
| Testosterone | 1 | 2022 | 2420 | 0.400 |
Why?
|
| Diabetes Complications | 1 | 2016 | 1359 | 0.340 |
Why?
|
| Blood Glucose | 3 | 2021 | 6256 | 0.330 |
Why?
|
| Infertility | 1 | 2015 | 655 | 0.320 |
Why?
|
| Genetic Testing | 1 | 2020 | 3444 | 0.300 |
Why?
|
| Health Care Costs | 1 | 2016 | 3209 | 0.220 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2020 | 5442 | 0.210 |
Why?
|
| Body Constitution | 1 | 2022 | 278 | 0.210 |
Why?
|
| Child | 9 | 2022 | 77709 | 0.210 |
Why?
|
| Addison Disease | 1 | 2020 | 48 | 0.190 |
Why?
|
| Blood Glucose Self-Monitoring | 2 | 2021 | 434 | 0.180 |
Why?
|
| Brain Neoplasms | 1 | 2020 | 8863 | 0.170 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2020 | 876 | 0.170 |
Why?
|
| Creatine Kinase | 1 | 2020 | 694 | 0.160 |
Why?
|
| Adrenal Insufficiency | 1 | 2020 | 184 | 0.160 |
Why?
|
| False Positive Reactions | 1 | 2020 | 981 | 0.160 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2022 | 11725 | 0.160 |
Why?
|
| Alopecia | 1 | 2022 | 382 | 0.160 |
Why?
|
| Insulin Infusion Systems | 1 | 2019 | 212 | 0.150 |
Why?
|
| Adolescent | 7 | 2021 | 85781 | 0.140 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2019 | 712 | 0.130 |
Why?
|
| Early Diagnosis | 1 | 2020 | 1184 | 0.130 |
Why?
|
| Receptors, Tachykinin | 1 | 2015 | 25 | 0.130 |
Why?
|
| Reference Standards | 1 | 2019 | 1025 | 0.130 |
Why?
|
| Tachykinins | 1 | 2015 | 78 | 0.130 |
Why?
|
| Sensitivity and Specificity | 2 | 2020 | 14722 | 0.120 |
Why?
|
| Sulfotransferases | 1 | 2015 | 151 | 0.120 |
Why?
|
| Radiotherapy Dosage | 1 | 2020 | 2879 | 0.120 |
Why?
|
| Body Mass Index | 2 | 2022 | 12720 | 0.120 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2015 | 250 | 0.120 |
Why?
|
| Receptors, Peptide | 1 | 2015 | 272 | 0.110 |
Why?
|
| Hyperglycemia | 1 | 2021 | 1373 | 0.110 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2021 | 1519 | 0.110 |
Why?
|
| Infrared Rays | 1 | 2014 | 249 | 0.110 |
Why?
|
| Age Factors | 2 | 2020 | 18370 | 0.110 |
Why?
|
| Humans | 14 | 2022 | 744343 | 0.100 |
Why?
|
| Male | 9 | 2022 | 350118 | 0.100 |
Why?
|
| Genetic Markers | 1 | 2018 | 2634 | 0.100 |
Why?
|
| Female | 9 | 2022 | 380194 | 0.100 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2015 | 849 | 0.090 |
Why?
|
| Infant, Newborn | 2 | 2020 | 25625 | 0.090 |
Why?
|
| Insulin | 2 | 2021 | 6580 | 0.080 |
Why?
|
| Follow-Up Studies | 2 | 2020 | 39050 | 0.080 |
Why?
|
| Retrospective Studies | 4 | 2022 | 77449 | 0.080 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2015 | 1222 | 0.070 |
Why?
|
| Pedigree | 1 | 2015 | 4644 | 0.070 |
Why?
|
| Hypoglycemic Agents | 1 | 2019 | 2872 | 0.070 |
Why?
|
| DNA Mutational Analysis | 1 | 2015 | 4186 | 0.070 |
Why?
|
| Diagnosis, Differential | 1 | 2020 | 12959 | 0.060 |
Why?
|
| Cost-Benefit Analysis | 1 | 2016 | 5391 | 0.060 |
Why?
|
| Diabetes Mellitus | 1 | 2021 | 5751 | 0.060 |
Why?
|
| Drug Delivery Systems | 1 | 2014 | 2219 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 1 | 2015 | 4462 | 0.050 |
Why?
|
| Child, Preschool | 2 | 2021 | 41006 | 0.050 |
Why?
|
| Time Factors | 1 | 2022 | 40075 | 0.050 |
Why?
|
| Asparaginase | 1 | 2021 | 236 | 0.050 |
Why?
|
| Genome-Wide Association Study | 1 | 2018 | 12261 | 0.040 |
Why?
|
| Incidence | 1 | 2016 | 20947 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2018 | 17446 | 0.040 |
Why?
|
| Polyethylene Glycols | 1 | 2021 | 1182 | 0.030 |
Why?
|
| Risk Factors | 1 | 2022 | 72290 | 0.030 |
Why?
|
| Nanocomposites | 1 | 2014 | 52 | 0.030 |
Why?
|
| Glucocorticoids | 1 | 2021 | 2107 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2014 | 712 | 0.030 |
Why?
|
| United States | 1 | 2016 | 69872 | 0.020 |
Why?
|
| Equipment Design | 1 | 2014 | 3582 | 0.020 |
Why?
|
| Adult | 1 | 2017 | 214055 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2014 | 8301 | 0.010 |
Why?
|
| Infant | 1 | 2021 | 35136 | 0.010 |
Why?
|
| Rats | 1 | 2014 | 24260 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 19905 | 0.010 |
Why?
|
| Animals | 1 | 2014 | 168757 | 0.000 |
Why?
|
Concepts
(91)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(27)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_